Find a Clinical Trial

Find cancer trials

Search by keyword, study number, or principal investigator.

You searched for:

Respiratory (Pulmonology)

34 search results

Medicine-Pulmonology

A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)

Location: Manchester

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis

Location: Manchester

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PTI-808 in Healthy Adult Subjects and in Adults with Cystic Fibrosis

Location: Manchester

A Phase 2 Study of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 in Subjects with Cystic Fibrosis who are Heterozygous for the F508del Mutation

Location: Manchester

A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis

Location: Manchester

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis

Location: Manchester

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation

Location: Manchester

A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation

Location: Manchester

A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)

Location: Manchester

A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Location: Manchester

A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects with Cystic Fibrosis of Chronic Pancreatitis Treated with Creon (Pancrelipase) with an Alternate Source of Active Pharmaceutical Ingredient

Location: Manchester

Alveolar Macrophage and Peripheral Blood Monocyte Dysfunction in Cystic Fibrosis

Location: Lebanon

An Observational Long-Term Safety Surveillance of Participants from Corbus Sponsored Lenabasum Pivotal Clinical Trials

Location: Manchester

Association of residential indoor particulate matter with respiratory outcomes in adults with cystic fibrosis

Location: Lebanon

Barriers to Palliative Care Referrals for Pulmonary Hypertension Patients

Location: Lebanon

Biofilm Formation, Antibiotic Resistance Phosphatidylcholine Utilization By Pseudomonas In Cf Sputum

Location: Lebanon, Manchester

COPD and Rural Health: Identifying Environmental Exposures Associated with Adverse Outcomes

Location: Lebanon

CliNIcal Utility of ManaGement of Patients witH CT and LDCT Identified Pulmonary Nodules UsinG the Percepta NasAL Swab ClassifiEr (NIGHTINGALE) -with Familiarization

Location: Lebanon

Cystic Fibrosis Foundation Patient Registry

Location: Lebanon, Bedford, Manchester

Evaluation of Autoimmunity in Patients with Non-CF Bronchiectasis

Location: Lebanon

Host Pathogen Interactions in GI Epithelium in Cystic Fibrosis

Location: Lebanon

Influences of temperature and humidity on CF outcomes including frequency of exacerbations and health care encounters

Location: Lebanon

Life after the ICU: Understanding patient needs and experiences

Location: Lebanon

Longitudinal Evaluation of Aspergillus Fumigatus in Patients with Cystic Fibrosis

Location: Lebanon

Lung Abscess and Complicated Pneumonia Database

Location: Lebanon

Mechanical Ventilation Simulation

Location: Lebanon

PHINDER: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection

Location: Lebanon

Perceptions and attitudes of patients at an academic pulmonary practice regarding implementation of Tele-Health clinic visits in a rural setting.

Location: Lebanon

Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis

Location: Lebanon, Manchester

Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis

Location: Lebanon, Manchester

Standardizing Treatments for Pulmonary Exacerbations: A Platform for evaluating treatment decisions to improve outcomes

Location: Lebanon

The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes

Location: Lebanon, Manchester

The Effects Of Systemic Anti-Pseudomonal Therapy On Fungal Load In Cystic Fibrosis

Location: Bedford

Validation of the coopeRATE Measure

Location: Lebanon

Looking for cancer trials? Visit our cancer site.